{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:23:02Z","timestamp":1791973382452,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/s11926-000-0059-x","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T15:28:47Z","timestamp":1180798127000},"page":"175-180","source":"Crossref","is-referenced-by-count":64,"title":["Bone and joint complications related to Gaucher disease"],"prefix":"10.1007","volume":"2","author":[{"given":"Gregory M.","family":"Pastores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manan J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossien","family":"Firooznia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"59_CR1","first-page":"621","volume-title":"Gaucher\u2019s disease","author":"RO Brady","year":"1997","unstructured":"Brady RO: Gaucher disease: past, present and future. In Gaucher\u2019s disease. Edited by Zimran, A. London: Balliere Tindall; 1997:621\u2013634.Provides historical account of the seminal studies that have eventually led to the introduction of enzyme replacement therapy."},{"key":"59_CR2","first-page":"739","volume-title":"In Gaucher\u2019s disease","author":"GM Pastores","year":"1997","unstructured":"Pastores GM: Pathological features. In In Gaucher\u2019s disease. Edited by Zimran, A. London: Balliere Tindall; 1997:739\u2013749.Succinct summary of pathophysiologic mechanisms underlying GD-related complications."},{"issue":"3","key":"59_CR3","first-page":"20","volume":"32","author":"GM Pastores","year":"1995","unstructured":"Pastores GM, Einhorn TA: Skeletal complications of Gaucher disease: pathophysiology, evaluation and treatment. Semin Hematol 1995, 32(3) Suppl 1:20\u201327.","journal-title":"Semin Hematol"},{"key":"59_CR4","first-page":"635","volume-title":"Gaucher\u2019s disease","author":"GA Grabowski","year":"1997","unstructured":"Grabowski GA, Horowitz M: Gaucher disease: molecular, genetic and enzymological aspects. In Gaucher\u2019s disease. Edited by Zimran, A. London: Balliere Tindall; 1997: 635\u2013656.Overview of biochemical and molecular basis of GD."},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/BF01716064","volume":"67","author":"H Christomanou","year":"1989","unstructured":"Christomanou H, Chabas A, Pampols T, Guardiola, A: Activator protein deficient Gaucher\u2019s. Klinische Wochenschrift. 1989, 67:999\u20131003.","journal-title":"Klinische Wochenschrift."},{"key":"59_CR6","first-page":"793","volume-title":"Gaucher\u2019s disease","author":"D Elstein","year":"1997","unstructured":"Elstein D, Itzchaki M, Mankin HJ: Skeletal involvement in Gaucher\u2019s disease. In Gaucher\u2019s disease. Edited by Zimran, A.London: Balliere Tindall; 1997:793\u2013816.Reviews the skeletal complications associated with GD and its management."},{"key":"59_CR7","first-page":"657","volume-title":"Gaucher\u2019s disease","author":"TM Cox","year":"1997","unstructured":"Cox TM, Schofield JP: Gaucher\u2019s disease: clinical features and natural history. In Gaucher\u2019s disease. Edited by Zimran,A. London: Balliere Tindall; 1997:657\u2013689."},{"issue":"1","key":"59_CR8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2106\/00004623-199601000-00003","volume":"78A","author":"K Katz","year":"1996","unstructured":"Katz K, Horev G, Grunebaum, M: The natural history of osteonecrosis of the femoral head in children and adolescents who have Gaucher disease. J Bone Joint Surg 1996, 78A(1):14\u201319.","journal-title":"J Bone Joint Surg"},{"key":"59_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003086-199701000-00007","volume":"334","author":"CJ Glueck","year":"1997","unstructured":"Glueck CJ, Freiberg R, Tracy T, et al.: Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthopaed & Related Research 1997, 334:43\u201356.Provides insight into the basis of osteonecrosis, a major GD-related complication, which may require an alternative therapeutic strategy other than ERT.","journal-title":"Clin Orthopaed & Related Research"},{"issue":"3","key":"59_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-2141.1997.d01-2076.x","volume":"96","author":"CE Hollak","year":"1997","unstructured":"Hollak CE, Levi M, Berends F, et al.: Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haemat 1997, 96(3):470\u2013476.Coagulation abnormalities may be a potential source of complications following orthopedic intervention and must be considered in the overall treatment plan.","journal-title":"Br J Haemat"},{"issue":"5","key":"59_CR11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","volume":"64","author":"DW Stowens","year":"1985","unstructured":"Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA: Skeletal complications of Gaucher disease. Medicine 1985, 64(5):310\u2013322.Reviews the types of bone involvement associated with GD and the natural history of the disease as it relates to skeletal complications.","journal-title":"Medicine"},{"issue":"1","key":"59_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","volume":"90","author":"MJ Allen","year":"1997","unstructured":"Allen MJ, Myer BJ, Khokher AM, et al.: Pro-inflammatory cytokines and the pathogenesis of Gaucher\u2019s disease: increased release of interleukin-6 and interleukin-10. QJM 1997, 90(1):19\u201325.","journal-title":"QJM"},{"issue":"1","key":"59_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00062752-199704010-00004","volume":"4","author":"E Beutler","year":"1997","unstructured":"Beutler E: Gaucher disease. Curr Opinion Hemat 1997, 4(1):19\u201323.","journal-title":"Curr Opinion Hemat"},{"issue":"8","key":"59_CR14","first-page":"1115","volume":"140","author":"PC Ruestow","year":"1980","unstructured":"Ruestow PC, Levinson DJ, Catchatourian R, et al.: Coexistence of IgA myeloma and Gaucher\u2019s disease. Arch Med 1980, 140(8):1115\u20131116.","journal-title":"Arch Med"},{"issue":"5","key":"59_CR15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2106\/00004623-199505000-00015","volume":"77","author":"MR Pins","year":"1995","unstructured":"Pins MR, Mankin HJ, Xavier RJ et al.: Malignant epithelioid hemangioendothelioma of the tibia associated with a bone infarct in a patient who had Gaucher disease: a case report. J Bone Joint Surg Am Vol 1995, 77(5):777\u2013781.","journal-title":"J Bone Joint Surg Am Vol"},{"issue":"1","key":"59_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y","volume":"72","author":"A Shiran","year":"1993","unstructured":"Shiran A, Brenner B, Laor A, Tatarsky: Increased risk of cancer in patients with Gaucher disease. Cancer 1993, 72(1):219\u2013224.","journal-title":"Cancer"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s002560050313","volume":"26","author":"G Herman","year":"1997","unstructured":"Herman G, Pastores GM, Abdelwahab IF, Lorberboym MA: Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement. Skeletal Radiol 1997, 26:687\u2013696.Reviews the various radiographic means of assessment for establishing the pattern of GD bone disease.","journal-title":"Skeletal Radiol"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00003086-198206000-00040","volume":"166","author":"T Matsubara","year":"1982","unstructured":"Matsubara T, Yashiga S, Maeda M, et al.: Histologic and histochemical investigation of Gaucher cells. Clin Orthop 1982, 166:233.","journal-title":"Clin Orthop"},{"issue":"2","key":"59_CR19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiology.182.2.1732964","volume":"182","author":"LA Johnson","year":"1992","unstructured":"Johnson LA, Hoppel BE, Gerard EL, et al.: Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiol 1992 182(2):451\u2013455.","journal-title":"Radiol"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1148\/radiology.161.1.3763873","volume":"161","author":"A Lanir","year":"1986","unstructured":"Lanir A, Hador H, Cohen I, et al.: Gaucher disease: assessment with MR imaging. Radiol 1986, 161:239.","journal-title":"Radiol"},{"key":"59_CR21","first-page":"479","volume":"20","author":"G Harev","year":"1991","unstructured":"Harev G, Kornreich L, Hadar H, et al.: Hemorrhage associated with \"bone crisis\" in Gaucher\u2019s disease identified by magnetic resonance imaging. Skeletal Radiol 1991, 20:479.","journal-title":"Skeletal Radiol"},{"key":"59_CR22","first-page":"247","volume":"22","author":"G Hermann","year":"1993","unstructured":"Hermann G, Shapiro R, Abdelwahab IF, et al.: MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol 1993, 22:247.","journal-title":"Skeletal Radiol"},{"key":"59_CR23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00003072-199608000-00006","volume":"21","author":"J Farahati","year":"1996","unstructured":"Farahati J, Trenn G, John-Mikolajewski V, et al.: Longitudinal studies by various diagnostic workup in a patient with Gaucher disease type I. Clin Nucl Med 1996, 21:619\u2013625.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"59_CR24","first-page":"890","volume":"38","author":"M Lorberboym","year":"1997","unstructured":"Lorberboym M, Pastores GM, Kim CK, et al.: Scintigraphic monitoring of patients with type 1 Gaucher disease on enzyme replacement therapy. J Nucl Med 1997, 38(6):890\u2013895.","journal-title":"J Nucl Med"},{"issue":"4","key":"59_CR25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF01247378","volume":"23","author":"G Mariani","year":"1996","unstructured":"Mariani G, Molea N, La Civita L, et al.: Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher\u2019s disease. Eur J Nucl Med 1996, 23(4):466\u2013470.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"59_CR26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiology.182.2.1732964","volume":"182","author":"G Hermann","year":"1992","unstructured":"Hermann G, Goldblatt J, Levy RN, et al.: Gaucher\u2019s disease type 1: assessment of bone involvement by CT and scintigraphy. Radiol 1992, 182(2):451\u2013455.","journal-title":"Radiol"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jbmr.5650111125","volume":"11","author":"GM Pastores","year":"1996","unstructured":"Pastores GM, Wallenstein S, Desnick RJ, Luckey M: Bone density in type 1 Gaucher disease. J Bone and Mineral Res 1996, 11:1801\u20131807.Addresses the role of bone density measurements in GD, providing the rationale for the potential use of bisphosphonates in the treatment of osteopenia associated with this disorder.","journal-title":"J Bone and Mineral Res"},{"key":"59_CR28","first-page":"817","volume-title":"Gaucher\u2019s disease","author":"PK Mistry","year":"1997","unstructured":"Mistry PK, Abrahamov A: A practical approach to diagnosis and management of Gaucher\u2019s disease. In Gaucher\u2019s disease.Edited by Zimran, A. London: Balliere Tindall; 1997:817\u2013838."},{"issue":"2","key":"59_CR29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.V82.2.408.408","volume":"82","author":"GM Pastores","year":"1993","unstructured":"Pastores GM, Sibille AR, Grabowski GA: Enzyme augmentation therapy in Gaucher diseases type 1: dosage efficacy and adverse effects. Blood 1993, 82(2):408\u2013416.A report on the clinical responses to ERT, using a singular approach (bimonthly intravenous infusions) in GD patients on various treatment doses (30-60 units\/kg).","journal-title":"Blood"},{"key":"59_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","volume":"122","author":"GA Grabowski","year":"1995","unstructured":"Grabowski GA, Barton N, Pastores GM, et al.: Enzyme therapy in Gaucher disease type 1: comparative efficacy of mannoseterminated glucocerebrosidase from natural and recombinant sources. Ann Med 1995, 122:33\u201339.","journal-title":"Ann Med"},{"key":"59_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s002560050120","volume":"25","author":"GM Pastores","year":"1996","unstructured":"Pastores GM, Hermann G, Norton K, et al.: Skeletal regeneration in a patient with Gaucher disease on enzyme replacement therapy. Skeletal Radiol 1996, 25:485\u2013488.","journal-title":"Skeletal Radiol"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF02019078","volume":"25","author":"GM Pastores","year":"1995","unstructured":"Pastores GM, Hermann G, Norton K, Desnick RJ: Resolution of a proximal humeral defect in type 1 Gaucher disease by enzyme replacement therapy. Pediatr Radiol 1995, 25:486\u2013487.","journal-title":"Pediatr Radiol"},{"key":"59_CR33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008814105603","volume":"7","author":"AM Damiano","year":"1998","unstructured":"Damiano AM, Pastores GM, Ware JE: The health-related quality of life of adults with Gaucher disease receiving enzyme replacement: results from a retrospective study. Qual Life Res 1998, 7:373\u2013386.Addresses the value of ERT in terms of improvements in quality of life as opposed to traditional means of quatitating clinical responses (eg, increase in blood counts, reduction in liver and spleen volume).","journal-title":"Qual Life Res"},{"issue":"3","key":"59_CR34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1542\/peds.94.3.385","volume":"94","author":"R Samuel","year":"1994","unstructured":"Samuel R, Katz K, Papapoulos SE, et al.: Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher\u2019s disease. Pediatr 1994, 94(3):385\u2013389.","journal-title":"Pediatr"},{"key":"59_CR35","first-page":"765","volume-title":"Gaucher\u2019s disease","author":"JA Barranger","year":"1997","unstructured":"Barranger JA, Rice EO, Dunigan J, et al.: Gaucher\u2019s disease: studies of gene transfer to haemopoietic cells. In Gaucher\u2019s disease. Edited by Zimran, A. London: Balliere Tindall;1997:765\u2013778."},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0006-2952(98)00115-4","volume":"56","author":"FM Platt","year":"1998","unstructured":"Platt FM, Butlers TD: New therapeutic prospects for the glycosphingolipid lysosomal storage decreases. Biochem Pharmacol 1998, 56:421\u2013430.","journal-title":"Biochem Pharmacol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0059-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-000-0059-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0059-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:25:02Z","timestamp":1683865502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-000-0059-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11926-000-0059-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}